Tilray Brands (TLRY) Net Cash Flow (2017 - 2026)
Tilray Brands' (TLRY) quarterly Net Cash Flow came in at -$20.3 million in Q2 2026, down 217.13% YoY from $17.4 million in Q2 2025, and down 1200.65% on a QoQ basis from $1.8 million in Q1 2026.
Tilray Brands (TLRY) Net Cash Flow (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Net Cash Flow data on file, last reported at -$20.3 million in Q2 2026.
- Quarterly Net Cash Flow fell 217.13% year-over-year to -$20.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $6.0 million (up 177.45% YoY) and the FY2026 annual result came in at $6.0 million, up 177.45% from the prior year.
- Net Cash Flow eased to -$20.3 million in Q2 2026, from $1.8 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $136.4 million in Q2 2022 to a low of -$299.4 million in Q4 2022.
- A 5-year average of -$5.7 million and a median of -$5.7 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow tumbled 578.83% — and 2025, when it surged 571.31%.
- Tracing TLRY's Net Cash Flow over 5 years: stood at -$299.4 million in 2022, then surged by 88.55% to -$34.3 million in 2023, then jumped by 61.36% to -$13.2 million in 2024, then slumped by 39.23% to -$18.4 million in 2025, then fell by 10.23% to -$20.3 million in 2026.
- The last three Net Cash Flow figures came in at -$20.3 million (Q2 2026), $1.8 million (Q1 2026), and -$18.4 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 519.72 Mn | 285.09 Mn | 90.52 Mn | -20.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -20.33 Mn |
| May 31, 2026 | -20.33 Mn |
| Feb 28, 2026 | 1.85 Mn |
| Feb 28, 2026 | 1.85 Mn |
| Nov 30, 2025 | -18.44 Mn |
| Nov 30, 2025 | -18.44 Mn |
| Aug 31, 2025 | 42.97 Mn |
| Aug 31, 2025 | 42.97 Mn |
| May 31, 2025 | 17.36 Mn |
| May 31, 2025 | 17.36 Mn |
| Feb 28, 2025 | 12.19 Mn |
| Feb 28, 2025 | 12.19 Mn |
| Nov 30, 2024 | -13.25 Mn |
| Nov 30, 2024 | -13.25 Mn |
| Aug 31, 2024 | -24.11 Mn |
| Aug 31, 2024 | -24.11 Mn |
| May 31, 2024 | 82.83 Mn |
| May 31, 2024 | 82.83 Mn |
| Feb 29, 2024 | 1.82 Mn |
| Feb 29, 2024 | 1.82 Mn |